{ }
UBS analyst Chen Chen upgraded Wuxi Apptec from Neutral to Buy, raising the price target from HK$40.10 to HK$70.40, citing signs of recovery in the CRO sector and growth in revenue and backlog. Despite disappointing Q3 results, the outlook is bolstered by potential biopharma funding from recent Federal Reserve rate cuts and Chinese economic stimulus. UBS has also revised its revenue, margin, and EPS estimates for 2025-2028, reflecting a more optimistic financial forecast for the company.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.